PRESS RELEASE published on 04/23/2025 at 16:35, 1 year 1 month ago Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025 Protagonist Therapeutics announces abstract acceptance at ASCO 2025 for Phase 3 study on Rusfertide in treating Polycythemia Vera Phase 3 Study Protagonist Therapeutics Rusfertide Polycythemia Vera ASCO 2025
PRESS RELEASE published on 04/23/2025 at 15:46, 1 year 1 month ago EQS-Adhoc: Deutsche Rohstoff AG: Consolidated financial statements, dividend proposal and guidance 2025/2026 Deutsche Rohstoff AG releases 2024 financial statements, dividend proposal, and 2025/2026 guidance with adjusted oil price assumptions and capex reduction Financial Statements Dividend Proposal Deutsche Rohstoff AG Oil Price Assumptions Guidance 2025/2026
PRESS RELEASE published on 04/23/2025 at 15:40, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.52% stake in Qualcomm Incorporated as of 22 April 2025. Additional disclosures related to Alphawave IP Group plc Vanguard Group Financial Disclosure Stake Disclosure Qualcomm Incorporated Alphawave IP Group
PRESS RELEASE published on 04/23/2025 at 15:39, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 11.26% stake in American Axle & Manufacturing Holdings, Inc. as of 22 April 2025 The Vanguard Group Stake Disclosure Financial Holdings Investment Disclosure American Axle & Manufacturing Holdings
PRESS RELEASE published on 04/23/2025 at 15:38, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses 3.33% stake in Dalata Hotel Group plc as of 22 April 2025 under Rule 8.3 of the Irish Takeover Panel Act The Vanguard Group, Inc. Irish Takeover Panel Rule 8.3 Dalata Hotel Group Plc Stake Disclosure
PRESS RELEASE published on 04/23/2025 at 15:38, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% stake in Mural Oncology plc through ownership of 772,615 ordinary shares as per Form 8.3 to the Irish Takeover Panel Form 8.3 Irish Takeover Panel The Vanguard Group Financial Disclosure Mural Oncology Plc
PRESS RELEASE published on 04/23/2025 at 15:37, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.37% stake in Greencore Group plc. Public position disclosure per Rule 8.3 of the Takeover Code on April 22, 2025 Disclosure Rule 8.3 Vanguard Group Inc. Takeover Code Greencore Group Plc
PRESS RELEASE published on 04/23/2025 at 15:36, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. discloses a 5.59% interest in Primary Health Properties plc's 12.5p ordinary securities. Additional position disclosed in Assura plc Securities Disclosure The Vanguard Group Relevance Primary Health Properties Plc
PRESS RELEASE published on 04/23/2025 at 15:35, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% stake in Direct Line Insurance Group plc as of 22 April 2025. Purchased additional securities at 2.77 GBP per unit The Vanguard Group Inc. Financial Disclosure Stake Disclosure Securities Purchase Direct Line Insurance Group Plc
PRESS RELEASE published on 04/23/2025 at 15:35, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses 5.63% ownership of Assura plc's 10p ordinary securities. Also, making disclosures related to Primary Health Properties plc The Vanguard Group, Inc. Ownership Disclosure 10p Ordinary Securities Assura Plc Primary Health Properties Plc
Published on 06/20/2026 at 01:00, 1 day 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 3 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 3 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 7 hours 27 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 22 hours 52 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 9 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 10 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 11 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 11 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
